Don’t Trade in the Dark—Get Your Pre-Market Report Every Day.Join Now
Sacheerome Ltd
| Q4 FY26 Earnings Conference Call
Summary : Sacheerome delivered exceptional FY26 results, is expanding capacity 4x with a new facility, and remains optimistic about future growth despite minor delays.
Management Perspective positive : Financial year '25-'26 has been an exceptional year for Sacheerome. We delivered our highest-ever revenue, EBITDA, and profit performance. We remain highly optimistic about Sacheerome's long-term growth trajectory. We are giving you conservative figure and we will try, we'll do our best.
Concall Report Analysis & Insights
Business Overview
- FY26 was an exceptional year with strong financial performance.
- Achieved highest-ever revenue, EBITDA, and profit performance.
- Operating at capacity utilization levels exceeding 120%.
- Laid strong foundation for growth with upcoming YEIDA manufacturing facility.
- Revenue from operations increased 41.71% to INR152.39 crores in FY26.
Future Growth Prospects
- New YEIDA facility will multiply production capacity by 4x.
- Guidance for FY27-FY29 revenue: INR200cr, INR250cr, INR300cr respectively.
- Focus on strengthening customer relationships and expanding into new segments/geographies.
- Continued investment in innovation, product development, and customized solutions.
- Expanding international presence and participating in World Perfumery Congress.
Management Insights
- FY26 was an exceptional year with strong financial performance and margin expansion.
- Performance reflects robust demand, business model resilience, and cost competitiveness.
- New YEIDA facility is a strategic investment for enhanced automation and export capabilities.
- We are a debt-free company with surplus funds for expansion.
- Focus on high-value, value-addition products and R&D-driven business.
Signs of Skepticism
- Analyst questioned if revenue guidance was conservative given 4x capacity increase.
- Analyst questioned if asset turnover would decrease with new capex.
- Analyst asked about specific revenue contribution from proprietary technologies, which management did not quantify.
Risk Factors
- Delay in new manufacturing facility due to vendor manpower and material issues.
- Geopolitical situations impacting raw material prices globally.
- New facility will incur high depreciation costs.
- Capacity utilization of new plant will be gradual, not immediate.
Good To Know
- Invested INR76.59 crores in YEIDA facility from IPO and internal accruals.
- Commercial operations for new facility expected to commence from August 2026.
- Operating margin for FY26 was approximately 25% (EBITDA margin 26.02%).
- Fragrance segment contributed 94% of revenue, flavor segment 6%.
- R&D spend is around 2.3% of total sales, focused on customer-specific solutions.
Key Drivers
- New facility multiplies capacity.
- Strong industry demand.
- Expanding global presence.
- Innovation drives products.
Key Analyst Discussions
Competitive Environment
- Questions about competitors in the listed and private space.
- Inquiries about what is changing in the industry to enable 4x-5x capacity increase.
- Discussion on market share gains, particularly from global companies.
- Management emphasized being a creative house, not a commodity player.
- Focus on Indian market first, then global expansion.
Market Trends & Consumer Behavior
- Questions on factors driving demand for capacity expansion.
- Discussion on evolving consumer preferences and increased spending power in India.
- Impact of COVID on consumer mindset towards hygiene and cleanliness.
- Growth in FMCG industry and demand for differentiated products.
- Rising consumption from FMCG categories and superior sensory experiences.
Financial Highlights
- Questions on current capacity utilization (120%+) and new capex details (INR184 crores).
- Inquiries about the impact of new capacity on revenue growth for the first half of FY27.
- Questions regarding the increase in operating margin due to lower cost increase vs. turnover.
- Clarification on asset turnover post-capex and its potential decrease.
- Inquiry about the dramatic improvement in cash conversion cycle from 109 to 35 days.
Product Composition
- Questions about new products or categories planned for the new facility.
- Inquiries about the margin profile of the flavor segment compared to fragrance.
- Discussion on R&D spend and whether R&D is done for customers.
- Management stated both fragrance and flavor segments have similar margins.
- New facility will allow faster growth in the flavor segment.
Strategic Considerations
- Questions about the timeline for the new YEIDA facility's commercial operations.
- Inquiries about the maximum topline achievable with the additional capex.
- Discussion on the gradual ramp-up of production at the new facility.
- Questions about the company's strategy for international expansion.
- Inquiry about the revenue contribution from proprietary technologies.